Heart patients prescribed opioids at hospital discharge often fare worse
Journal of the American Heart Association Report
- Heart disease patients prescribed opioids at hospital discharge were less likely to follow up with their healthcare provider or to participate in heart rehabilitation than those not prescribed opioids.
- These patients were slightly more likely than other patients to require additional hospital or emergency room treatment, or to die during the study.
DALLAS, Jan. 30, 2019 — Heart disease patients prescribed opioids at hospital discharge were less likely to follow up with their healthcare provider or to participate in heart rehabilitation than patients who were not, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
As the nationwide opioid epidemic continues, the risks versus benefits of these strong painkillers are being questioned. Previous research found health problems among patients prescribed opioids for non-cancer-related pain and a recent study linked opioid use to an increase risk of atrial fibrillation.
In this study, researchers analyzed 2,495 patients (mostly white males; average age 60) discharged from Vanderbilt University Medical Center for heart attack, sudden heart failure, or both between October 2011 and December 2015. Twenty percent of patients were discharged with an opioid prescription.
Compared to those not prescribed opioids at discharge, researchers found patients prescribed opioids were:
- less likely to follow up with their healthcare provider or participate in heart rehabilitation thirty days after discharge; and
- slightly more likely to visit the emergency room, be readmitted to the hospital, or to die within 90 days.
“Hospital discharge provides a unique opportunity to evaluate each patient’s medication regimen,” said study lead author Justin S. Liberman, M.D., M.P.H., assistant professor of anesthesiology at Vanderbilt University Medical Center in Nashville, Tennessee. “It’s important for healthcare providers to understand the other ways that opioids may affect a patient’s future interactions with the healthcare system.”
Researchers reviewed patients’ medical records through the Vanderbilt Inpatient Cohort Study. After hospital discharge, participants provided information by telephone interview about their use of medical services. Interviews occurred 2-3 days, 30 days and 90 days after discharge.
The study shows an association but does not prove that opioid prescriptions caused patients to miss follow-up care. Researchers said, it’s possible that diminished physical and mental function, known effects of opioids, contributed.
The study may be limited by a lack of information about the number of opioids taken and their duration of use. Also, the study focused on one hospital with a primarily white population and may not apply to others.
Co-authors are Lauren R. Samuels, Ph.D.; Kathryn Goggins, M.P.H.; Sunil Kripalani, M.D., M.Sc.; and Christianne L. Roumie, M.D., M.P.H. Author disclosures are on the manuscript.
The National Heart, Lung, and Blood Institutes, the National Center for Advancing Translational Sciences, and the Vanderbilt Department of Anesthesia, the Office of Academic Affiliations, and the V.A. Quality Scholars program supported the study.
- Available multimedia is on right column of release link - https://newsroom.heart.org/news/heart-patients-prescribed-opioids-at-hospital-discharge-often-fare-worse
- View the manuscript online.
- American Heart Association introduces opioid education courses for healthcare providers and lay responders
- Opioid use may increase risk of dangerous heart rhythm disorder
- Follow AHA/ASA news on Twitter @HeartNews
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.
About the American Heart Association
The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173
Karen Astle: 214-706-1392; email@example.com
For Public Inquiries: 1-800-AHA-USA1 (242-8721)